NYSE$CHCT
Community Healthcare Trust Incorporated · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Reported a net income of $1.7 million, or $0.04 per diluted common share, for Q3 2024.
Community Healthcare Trust reported a net income of $1.7 million, or $0.04 per diluted common share, for the three months ended September 30, 2024. FFO was $0.48 per diluted common share and AFFO was $0.55 per diluted common share.
- Acquired one physician clinic for approximately $6.2 million.
- Disposed of a surgical center in Texas for net proceeds of approximately $1.0 million.
- Entered into a second Amendment to the third amended and restated credit agreement, increasing the Revolving Credit Facility from $150.0 million to $400.0 million and extending the maturity date to October 16, 2029.
- Declared a quarterly common stock dividend of $0.465 per share.
Headline financials
Revenue & EPS history
CHCT · Revenue · Quarterly
$29.6M
Revenue by segment
CHCT · $28.7M total across 2 segments · Q3 2023
- Rental Income$27.7M+15.8%96.4%
- Other Operating Interest$1.05M+17.7%3.6%
Forward guidance
The Company has four properties under definitive purchase agreements for an aggregate expected purchase price of approximately $8.8 million. The Company also has seven properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $169.5 million.
Tailwinds
- Expected returns on the $8.8 million investments range from 9.29% to 9.50%.
- Expected returns on the $169.5 million investments are approximately 9.1% to 9.75%.
- The Company expects to close on the properties in the fourth quarter of 2024.
- Anticipates closing on the other properties throughout 2025, 2026 and 2027.
- Increased the Company's Revolving Credit Facility from $150.0 million to $400.0 million, extended the maturity date of the Revolving Credit Facility from March 19, 2026 to October 16, 2029, and lowered pricing on the Revolving Credit Facility by 10 to 30 basis points, depending on the Company's leverage ratio.
Headwinds
- The Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.
- Real estate values have historically risen or fallen with market conditions.
- General volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, the Company’s ability to refinance existing indebtedness at or prior to maturity on favorable terms, or at all, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, the conflicts in Ukraine and the Middle East, and/or uncertainties related to the 2024 U.S. presidential election, and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, and the Company’s other filings with the Securities and Exchange Commission from time to time.
- FFO and AFFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of the Company's financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company’s liquidity, nor are they necessarily indicative of sufficient cash flow to fund all of the Company’s needs.
- The Company’s actual results and financial condition may differ materially from those indicated in forward-looking statements.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
-0.2%
Avg return
Earnings day
-0.8%
Avg return
5 days after
-2.9%
Avg return
30 days after
47%
20 / 43 earnings
Positive
+9.8%
Q2 2020
Best reaction
-18.9%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.9% | -4.7% | -0.8% | |
| Q4 2025 | -4.7% | -9.4% | -13.8% | |
| Q3 2025 | -0.3% | +1.0% | +7.7% | |
| Q1 2025 | +5.0% | +5.0% | +0.5% | |
| Q4 2024 | -6.3% | -7.0% | -8.0% | |
| Q3 2024 | +6.8% | +3.8% | +6.0% | |
| Q2 2024 | -18.9% | -25.2% | -30.2% | |
| Q1 2024 | -6.2% | -8.9% | -14.2% | |
| Q4 2023 | +0.1% | -1.3% | -4.7% | |
| Q3 2023 | -1.6% | -1.0% | -3.9% | |
| Q2 2023 | +2.7% | +3.4% | -5.8% | |
| Q1 2023 | -0.0% | +1.6% | -9.0% | |
| Q4 2022 | -1.6% | -2.1% | -12.7% | |
| Q3 2022 | +0.9% | +2.0% | +2.7% | |
| Q2 2022 | +0.7% | -0.7% | -9.0% | |
| Q1 2022 | +2.1% | +3.4% | +1.9% | |
| Q4 2021 | +4.2% | +3.2% | -3.4% | |
| Q3 2021 | -3.5% | -2.0% | -10.0% | |
| Q2 2021 | -1.6% | +1.1% | +1.3% | |
| Q1 2021 | -3.9% | -1.7% | -4.9% | |
| Q4 2020 | +0.9% | -0.4% | -1.1% | |
| Q3 2020 | +3.9% | -0.4% | -2.3% | |
| Q2 2020 | +9.8% | +9.9% | +4.6% | |
| Q1 2020 | +7.2% | +5.8% | +4.6% | |
| Q4 2019 | -1.7% | -6.8% | -34.8% | |
| Q3 2019 | -4.9% | -6.6% | -1.8% | |
| Q2 2019 | +3.1% | +3.2% | +2.9% | |
| Q1 2019 | -1.9% | -0.1% | +3.4% | |
| Q4 2018 | -4.7% | -5.9% | +1.3% | |
| Q3 2018 | +1.1% | +1.8% | +5.9% | |
| Q2 2018 | +2.7% | +3.4% | +0.3% | |
| Q1 2018 | +0.2% | -0.8% | +2.2% | |
| Q4 2017 | +7.8% | +5.1% | +10.7% | |
| Q3 2017 | -3.2% | -1.6% | -3.0% | |
| Q2 2017 | -0.2% | +2.1% | +9.4% | |
| Q1 2017 | +2.9% | +1.4% | +2.0% | |
| Q4 2016 | +3.3% | +4.7% | +1.1% | |
| Q3 2016 | -7.3% | -6.4% | +0.4% | |
| Q2 2016 | -0.5% | -2.1% | -7.6% | |
| Q1 2016 | +2.4% | — | — | |
| Q4 2015 | -0.7% | — | — | |
| Q3 2015 | -1.4% | — | — | |
| Q2 2015 | -0.1% | — | — | |
| Q3 2014 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro